Introduction: Renal transplant outcomes result from a combination of factors.
| METHODS

| Patients
Following institutional review board approval, a retrospective chart review was conducted of 2161 patients receiving kidney transplantation at University of Wisconsin between 1999 and 2013. Eligibility requirements included: recipient age >18 and single organ kidney transplantation from a deceased donor. Patients were excluded if they received living donor transplants, kidney-pancreas transplants, and dual kidney transplants or if KDPI could not be calculated based on donor information available.
| KDPI calculations
All KDPI scores were calculated using the OPTN calculation formula. 5 In this calculation, 10 donor characteristics (age, height, weight, ethnicity, history of hypertension, history of diabetes, cause of death, creatinine, HCV status, and DCD status) are multiplied by their beta coefficient (Table 1 ) and summed to determine a XBETA.
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The KDRI_RAO is calculated by taking the exp(XBETA). The KDRI_ MEDIAN is calculated by dividing by the KDRI_RAO by a scaling factor provided by the OPTN based on the kidney donors recovered from the previous year. Finally, using the KDRI to KDPI mapping table provided by the OPTN, all KDPIs were derived from the calculated KDRIs.
| Study groups
Once KDPIs were determined for all patients, they were divided into 3 groups based on presumed risk. Low-risk, high-quality kidneys were defined as KDPIs ≤60. The moderate-risk, moderate-quality group consisted of kidneys with KDPIs between 61 and 84. The high-risk, poor-quality kidney group consisted of kidneys with KDPIs ≥85.
Clinically, it is well documented that differences exist between a donor after brain death (DBD) and donor after cardiac death (DCD) kidney related to warm ischemia time. 6, 7 As a result, our three groups were further subdivided by type of deceased donor. Our final six com- 
| Primary and secondary outcomes
The primary outcome measured was rates of DGF and the effect of DGF on graft survival for kidneys of differing KDPIs. In addition to determining the frequency of DGF in each group, we also assessed severity by determining the number of hemodialysis (HD) treatments in the post-transplant period. Our secondary outcomes were overall death-censored graft survival and patient survival using Kaplan-Meier survival analysis. Additionally, Cox proportional hazards regression analysis was performed to determine the association between deathcensored graft survival in our respective six groups after controlling for transplant number, cold time, recipient and donor sex, pretransplant dialysis, induction, and recipient age.
All transplant outcomes were first analyzed between all six groups to determine trends. Next, the groups were compared to each other.
First, all DBD kidneys with varying KDPIs were examined. Second, all DCD kidneys with varying KDPIs were examined. Third, DCD and DBD kidneys with equivalent KDPIs were analyzed. Using Cox proportional hazards regression and logistic regression analysis, odds ratio (OR) and hazard ratio (HR) for DGF and death-censored graft failure were calculated comparing each group to the most common kidney transplanted (DBD KDPI ≤60). In these models, transplant number, cold time, recipient and donor sex, pretransplant dialysis, induction, and recipient age were controlled for, given that we saw statistically significant differences in these factors when recipient and donor demographics were examined. We did not control for donor age, BMI, race, and cause of death in our models as these were components of the KDPI equation.
We finally compare the impact of DGF on the graft half-life of the transplanted kidney among the same donor types with similar KDPIs.
To determine graft half-life, graft loss was defined according to patient death, graft removal, or return to dialysis based on actuarial rates.
| Statistics
Statistical analysis was performed with SAS software, and P- 
| RESULTS
A total of 2161 kidney transplant patients were included in our analysis. 
| Recipient demographics
When examining recipient demographics (Table 2) , there was no statistical difference between the BMI, race, or number of months of pretransplant dialysis of the patients receiving kidneys from different groups.
Recipient patient age was found to be statistically different (P ≤ .001)
with the DBD and DCD kidneys with KDPIs ≤60 being allocated to the youngest patients at 48.4 ± 13.0 years and 50.2 ± 12.2 years, respectively. In contrast, the DBD and DCD kidneys with KDPI ≥85 were allocated to the oldest patients with mean ages of 60.6 ± 9.0 years and 61.0 ± 8.7 years. There were also differences in recipient gender, type of 
| Donor demographics
We noted statistically significant differences in age, BMI, race, and cause of death among our groups. We also noted differences in donor gender, cytomegalovirus status, and Epstein-Barr virus status (Table 3 ).
| Transplant outcomes
All transplant outcomes were compared first between all six groups (Table 4 ) and then groups were compared to each other (Table 5 ). Warm ischemia time (min) n/a n/a n/a 34. Using Cox proportional hazards regression and logistic regression analysis, OR and HR for DGF and graft failure were calculated comparing each group to DBD KDPI ≤60 kidneys (Table 6 ).
| Primary outcomes: impact of KDPI on DGF
| Post-transplant rates of DGF
The primary outcome analyzed was post-transplantation rates of DGF.
The highest rates of DGF were in the DCD KDPI ≥85 kidneys (55.3%),
followed by the DCD KDPI 61-84 kidneys (49.1%), DCD KDPI ≤60 kidneys (45.1%), DBD KDPI ≥85 (31.5%), DBD KDPI 61-84 (29%), and finally DBD KDPI ≤60 (18.7%) (P < .001) ( Table 4 ). We noted that 18 patients who met DGF criteria (requiring dialysis within the first week post-transplant) were preemptive transplant patients who had not previously been on dialysis.
When analyzing rates of DGF in DBD kidneys with varying KDPIs, there were statistically significant differences between the KDPI ≤60 and both KDPI 61-84 and KDPI ≥85 groups (P = .001) ( 
| Graft half-life by DGF status
Next, we examined the impact DGF status had on graft half-life for each subgroup ( 
| Secondary outcomes: graft and patient survival
| Graft survival and graft half-life
There was a statistically significant difference in renal graft survival (P ≤ .001) among the six groups displayed on the Kaplan-Meier curve in Figure 1 . The graft survival at 5 years was highest in the DCD kidneys with KDPI ≤60 (87.4%), followed by the DBD kidneys with KDPI ≤60 (84.8%). Conversely, the poorest 5-year graft survival was noted in DBD KDPI ≥85 kidneys (66.6%). DCD and DBD kidneys with KDPI 
| Patient survival
There was a significant difference in patient survival (P ≤ .001) among the six groups (displayed on the Kaplan-Meier curve in Figure 2 ). The highest 5-year patient survival was the DCD kidneys with KDPI ≤60 (86.7%), followed by the DBD kidneys with KDPI ≤60 (85.8%). The worst 5-year patient survival was in DCD KDPI ≥85 kidneys (59.5%), followed by DBD KDPI ≥85 (63.4%). DCD and DBD kidneys with KDPI 61-84 had 5-year patient survivals of 75% and 76.3%.
In DBD kidneys with varying KDPIs, there were significant differences in 5-year patient survival between all groups of increasing KDPI (P ≤ .030) ( 
| DISCUSSION
This study demonstrates that the KDPI system is an accurate predictor of donor contributions to transplant outcomes. DCD kidneys have higher DGF rates than their DBD counterparts with similar KDPIs and patients with documented post-transplant DGF had poorer graft halflives. Despite higher rates of DGF, the DCD kidneys did not show increased graft failure or patient mortality when compared to DBD kidneys of equivalent KDPI.
When designing this study, the authors decided to divide the subgroups not simply by KDPI, but also with regard to type of donor (DCD vs. DBD) despite this factor being a component of the KDPI equation for several reasons. It has been our experience that when discussing kidney quality and risks, many clinicians discuss DCD status as a risk factor separate from ECD/KPDI classification. In fact, some transplant programs do not consider DCD kidneys for transplant in select patients based on the presumption that these kidneys are considered an expanded resource and associated with a high failure rate. Our results directly contradict this conclusion by demonstrating the recipients of DCD kidneys have improved graft survival when compared to recipients of DBD kidneys of equivalent KDPI score. In addition, by categorizing transplant outcomes based on both donor type and KDPI score, we are able to better anticipate resources needed to care for these patients and can more accurately advise patients on their individual longterm results. Furthermore, clinical and basic science research aimed at improving transplant outcomes are better able to identify and target specific donor groups where improvement is most needed.
When examining the outcomes in terms of recipient demographics, there were many interesting trends. One of the goals of the adaptation of the KDPI scoring system was to better match patients with longer estimated post-transplant longevity with lower KDPI kidneys.
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This goal correlated with our observations that both DBD and DCD kidneys with KDPIs ≤60 were being allocated to the youngest patients in our study. Furthermore, a study by Massie et al 8 
demonstrated that
patients who are >50 years old and at centers with >33 month transplant wait times benefit most from high-KDPI kidney transplantation.
In our data, the oldest patients and populations with higher pretransplant dialysis rates received DBD and DCD kidneys with KDPI ≥85.
Another interesting trend from our recipient demographics data was that patients undergoing retransplant were more likely to have a KDPI ≤60 or KDPI 61-84. Although there is no literature to date on outcomes of retransplant in high-KDPI patients, a study done by Sellers et al 9 did find the relative risk of death-censored graft loss was 1.58 in the ECD group compared to SCD. It stands to reason KDPI ≥85 kidneys will have similar outcomes, and it is therefore appropriate that they are not currently being allocated to retransplant patients in great numbers.
The differences in cold time between kidney recipients in our study were likely an institutional bias due to an internal policy requiring DCD kidneys to have an OR time within 12 hours of procurement. As DGF. In our study, DCD patients with KDPIs <84% who suffered from DGF had between 3-and 4-year shorter half-lives than those with similar KDPIs who did not experience DGF. We were unable to calculate the half-life difference in the DCD, KDPI ≥85 group due to our small sample size, which is a limitation of our study. When examining all-comer DCD kidneys, we noted the graft half-life for a DCD KDPI ≥85 kidney was 10 years compared to 8.25 years in KDPI 61-84 kidneys. This phenomenon is likely explained by institutional biases. It is common practice in our hospital to prioritize operating room time for our higher risk DCD kidney and limit their cold ischemia time. A study out of the UK demonstrated increased graft survival with DCD kidneys in which the cold ischemia time was <12 hours. 23 Our study had several limitations. First, given this is a retrospective analysis of a single center's kidney transplant outcomes, our data can only suggest a correlation between KDPI and patient outcomes, and not a cause and effect relationship. As stated above, the sample size for our DCD KDPI >85% group is small, and therefore it is difficult to draw definitive conclusions of comparisons made with this group. Furthermore, our study spans an extended period of time in which the nomenclature changed from ECD/SCD to KDPI.
As a result, all of the KDPIs prior to 2014 were calculated based on the 2014 kidney allocation pool, not the allocation pool of the year that the kidneys were transplanted. Finally, given our center has relatively short cold ischemia times (especially in the case of DCD kidneys), routinely pumps our kidneys and transplants a predominately Caucasian recipient population with lower KDPI kidneys, there is an inherent selection bias to our data and our results may not be completely generalizable to other centers with different practice patterns and patient populations.
| CONCLUSION
The new KDPI system is an accurate predictor of donor contributions to transplant outcomes as rates of DGF and graft failure increase with increasing KDPI in all patients. When examining patients at risk for DGF, DCD status is the strongest factor contributing to the development of DGF. For those kidneys that did undergo DGF, there was a consistent trend of decreased graft half-life when compared to similar kidneys in terms of KDPI and DCD/DBD status which did not undergo DGF.
When determining risk of patient or graft survival, increasing KDPI is a more powerful predictor than DCD vs DBD status given there are no differences between DBD and DCD kidneys with similar KDPIs.
